# Human Skin Safety Testing of 6 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers

> **NCT07100912** · NA · COMPLETED · sponsor: **Amazentis SA** · enrollment: 113 (actual)

## Conditions studied

- Irritation/Irritant
- Sensitisation

## Interventions

- **OTHER:** Mitopure Topical Formula 5
- **OTHER:** Mitopure Topical Formula 6
- **OTHER:** Mitopure Topical Formula 7
- **OTHER:** Mitopure Topical Formula 8
- **OTHER:** Mitopure Topical Formula 9
- **OTHER:** Mitopure Topical Formula 10

## Key facts

- **NCT ID:** NCT07100912
- **Lead sponsor:** Amazentis SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-18
- **Primary completion:** 2025-09-26
- **Final completion:** 2025-09-26
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2025-11-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07100912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07100912, "Human Skin Safety Testing of 6 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07100912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*